Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	33.5	24.9	5.9	16.4	11.5	70.1	20.4	4.9	8.6	16.2	14.4	11.4	13.9	5.1	12.9	9.6	25.9	35.8	28.7	19.7	5.4	5.3	9.6	33.3	35.7	7.9	8.8	3.3	24.9	16.3	11.7	17.6	30.9	15.3	15.8	6.8	9.7	10.9	50.1	22.4	19.9	21.0	26.9	11.9	9.2	20.3	11.4	7.5	8.9	14.5	14.6	7.8	21.4	16.9	3.6	3.9	15.9	9.2	2.2	2.5	1.9	2.3	5.3	1.4	2.7	2.7	2.8	4.4	8.7	12.3	7.3	6.0	7.5	2.2	7.8	1.9	6.6	5.3	2.7	1.6	11.6	3.6	11.6	2.2	8.9	4.3	5.6	3.3	2.2	8.9	1.3	6.3	11.5	1.8	6.6	9.9	2.1	6.7	13.9	6.0	7.5	0.4	3.6	6.4	4.0	4.5	3.6	5.8	12.7	5.8	8.7	3.9	0.6	4.8	36.2	2.9	8.6	4.0	4.1	4.9	3.7	16.0	3.1	6.4	3.6	3.0	3.6	8.2	2.8	4.6	0.1	2.7	3.2	1.7	5.6	2.1	3.6	1.6	1.9	3.0	3.6	2.0	1.3	15.9	2.2	9.2	3.9	2.5	1.9	5.9	11.5	4.9	8.6	5.4	5.3	8.8	3.3	15.3	7.5	44.7	66.0	21.2	65.0	91.8	1.4	12.9	17.8	9.4	17.0	10.4	0.0	13.0	8.3	30.2	47.7	63.8	51.3	23.3	34.0	40.3	70.9	58.0	96.7	34.8	35.2	0.0	56.9	49.7	35.1	34.1	1.4	49.4	65.8	20.8	34.8	4.3	37.1	28.1	3.9	4.8	1.6	12.9	150.2	0.2	3.2	69.5	75.9	27.7	25.5	32.3
CSRNP2	"C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12"	ENSG00000110925	"Cysteine and serine rich nuclear protein 2"	Q9H175	12	51061205-51083664	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018503, HPA019914"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018503: AB_1845535, HPA019914: AB_2670315"	"unprognostic (8.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.74e-2)"	"prognostic favorable (2.78e-4)"	13.7	12.3	14.7	8.0	16.5	3.5	22.2	23.3	26.4	13.3	9.2	11.4	6.0	7.6	16.1	14.2	9.0	9.6	13.3	11.8	14.0	16.2	10.4	7.9	9.7	9.3	12.7	13.5	14.7	10.4	11.2	15.7	12.8	13.3	11.3	8.2	11.7	8.6	12.8	15.8	8.9	7.1	16.7	11.4	9.6	8.3	32.1	12.8	12.1	13.0	8.3	7.7	11.2	9.0	1.2	0.9	2.6	0.9	5.9	2.7	0.4	5.5	6.2	19.0	16.9	14.6	10.4	20.2	10.9	12.3	15.0	10.4	11.9	4.0	4.6	10.8	11.4	10.3	6.7	9.2	5.9	12.0	10.0	7.0	5.4	7.1	3.7	16.0	3.7	8.3	12.6	16.7	17.4	10.0	16.5	14.7	21.1	7.7	8.2	17.3	9.4	12.9	5.2	15.7	2.5	9.8	7.8	12.3	3.6	8.6	7.1	13.5	16.0	15.9	12.5	15.9	14.0	7.9	10.4	13.3	15.0	8.0	10.0	7.4	9.0	9.9	4.3	9.2	5.0	4.8	0.0	0.9	2.3	1.9	0.1	0.7	1.2	2.0	1.1	0.9	0.7	2.0	2.7	2.6	5.9	0.6	0.4	1.3	0.4	14.7	16.5	23.3	23.2	14.0	16.2	12.7	13.5	13.3	12.8	3.0	5.0	4.2	10.0	15.9	6.6	14.6	2.5	4.0	2.3	5.2	23.6	5.5	3.3	6.2	18.8	15.5	9.5	0.0	4.4	6.7	12.2	9.1	11.5	2.4	5.5	6.4	7.9	11.1	5.3	11.7	5.8	5.2	15.1	3.6	5.9	5.8	6.1	5.8	7.4	3.3	7.5	0.0	24.7	30.4	15.1	14.1	12.6	5.0	5.0	4.8
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.7;pituitary gland: 21.1"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 49.8;Cone photoreceptor cells: 66.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.9;PC-3: 3.1;SCLC-21H: 9.5;SH-SY5Y: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Approved		Uncertain	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	2.1	5.5	9.3	1.4	24.9	0.7	6.7	8.8	31.7	5.7	2.0	3.2	0.4	2.1	6.3	2.3	2.0	2.5	2.5	3.4	9.3	10.2	3.7	1.8	1.4	1.1	5.3	13.2	7.8	8.0	6.0	21.1	1.1	7.8	3.9	2.5	4.0	4.9	5.1	0.9	2.1	1.7	5.7	2.9	2.1	2.0	1.9	4.8	0.0	5.3	0.0	1.0	1.9	2.5	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.9	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.1	0.8	0.7	0.0	9.5	7.7	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.8	0.3	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	24.9	8.8	31.7	9.3	10.2	5.3	13.2	7.8	4.8	3.0	3.2	0.0	2.6	4.6	49.8	6.7	10.2	0.0	1.2	10.4	66.8	0.3	3.3	1.8	2.5	2.9	0.5	0.0	2.1	0.1	4.7	0.3	0.0	2.9	2.0	11.1	7.5	1.3	0.3	1.3	6.9	0.0	6.8	0.0	2.6	18.3	1.0	1.9	7.8	5.0	17.9	6.5	14.6	0.7	0.7	4.0	0.2	0.0	2.9	1.4
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627576-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 74.5"									HPA006979	Approved		Supported	Cytosol		NA	NA		120000	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	27.2	9.9	11.2	28.6	9.4	28.5	31.3	8.8	14.5	28.0	30.9	5.4	16.4	13.7	36.3	24.1	30.1	18.5	23.3	30.7	11.1	12.0	32.1	27.6	29.9	25.5	7.7	10.0	18.0	10.4	31.3	14.2	16.8	12.2	27.5	16.3	8.2	20.2	14.4	52.7	12.6	19.8	56.8	7.4	27.9	21.5	7.3	5.8	27.6	19.0	23.1	19.4	49.3	39.5	12.8	17.6	71.6	33.1	9.3	19.9	10.6	22.7	11.8	5.6	11.3	8.0	16.0	18.9	17.1	16.5	9.3	9.3	4.5	15.3	1.9	6.9	26.3	20.1	19.1	12.8	23.7	19.9	74.5	8.3	18.1	13.4	12.7	16.2	23.8	17.2	7.2	49.8	21.6	53.1	13.9	18.8	12.8	13.3	18.7	19.9	11.0	13.7	18.2	7.4	17.0	10.9	20.5	33.0	18.5	29.8	33.3	11.5	7.7	7.9	18.3	21.7	10.6	10.3	30.1	32.9	11.3	10.9	12.1	18.0	3.8	3.2	12.7	16.4	24.1	12.3	14.3	22.8	49.4	16.5	19.7	12.4	11.0	19.9	17.1	17.6	12.8	10.6	11.8	71.6	9.3	33.1	15.5	15.3	10.6	11.2	9.4	8.8	14.5	11.1	12.0	7.7	10.0	12.2	5.8	452.6	296.6	160.3	309.8	272.8	47.5	137.7	124.9	346.6	384.5	164.0	35.3	90.2	44.7	209.5	8.0	199.3	165.6	0.0	289.9	289.9	102.6	382.8	229.3	128.8	162.7	20.6	182.9	86.5	247.2	5.6	27.6	484.3	158.6	206.4	114.8	21.5	281.3	91.1	21.9	38.3	5.6	77.6	225.8	8.8	35.9	212.4	21.2	230.4	94.7	523.2
LRRFIP2	HUFI-2	ENSG00000093167	"LRR binding FLII interacting protein 2"	Q9Y608	3	37052656-37183689	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 388.9;Urothelial cells: 309.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035956, HPA042023"	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA		1000000	"Plasma membrane, Actin filaments"		"HPA035956: AB_10671238, HPA042023: AB_2677802"	"unprognostic (2.03e-3)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.16e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.76e-2)"	15.4	17.3	23.0	17.5	22.0	27.5	21.9	30.0	22.8	35.7	35.8	26.5	17.7	24.7	28.2	20.0	33.0	15.7	22.8	47.4	23.8	25.3	19.8	33.9	18.7	19.3	24.2	19.4	20.6	16.9	33.9	18.3	16.9	24.4	30.3	24.8	19.6	19.3	19.5	58.5	23.2	37.1	27.3	31.2	29.7	17.0	47.2	24.8	11.6	20.6	33.6	21.6	23.7	25.1	7.1	9.8	22.7	17.2	11.9	8.8	7.5	15.6	8.7	10.1	7.9	13.5	20.8	8.8	42.7	42.6	24.1	27.8	8.1	7.2	6.2	7.0	41.1	11.9	8.2	7.4	21.1	39.5	13.8	5.8	11.1	12.5	7.9	19.3	8.7	6.8	9.2	15.2	31.3	32.5	13.4	16.7	9.7	8.8	10.9	20.0	4.0	7.4	4.7	6.6	6.4	11.2	3.6	28.9	6.3	16.9	6.1	3.6	5.8	16.5	15.3	13.8	8.5	8.8	9.1	16.0	18.5	12.5	27.1	20.0	8.5	15.2	9.5	10.9	7.9	26.2	12.2	15.0	22.7	6.6	10.4	8.5	7.1	7.0	7.0	9.8	5.4	5.2	6.2	14.0	11.9	17.2	5.5	8.8	7.5	23.0	22.0	30.0	22.8	23.8	25.3	24.2	19.4	24.4	24.8	26.8	32.2	18.0	127.0	120.9	34.6	89.3	25.5	36.1	66.0	22.7	27.5	25.5	54.7	70.3	388.9	46.3	105.3	23.3	82.3	35.6	59.0	267.5	50.8	52.9	22.7	116.0	51.9	60.8	39.4	269.5	39.1	42.2	70.9	77.5	39.2	48.7	85.8	59.6	54.1	33.1	51.1	38.8	54.0	116.1	61.4	149.1	32.8	24.5	60.8	309.6
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.3	12.5	11.5	10.9	17.2	19.4	11.6	14.5	14.5	16.5	16.5	11.4	6.3	23.8	9.3	16.7	11.1	8.7	20.5	15.7	15.5	17.4	10.3	12.5	30.6	12.7	21.0	22.2	13.9	18.1	26.3	14.0	35.5	14.8	10.0	13.6	19.0	20.8	17.2	10.8	14.3	20.9	18.7	11.3	14.2	15.4	12.6	13.0	11.1	14.7	16.0	11.2	14.5	15.7	8.3	14.2	9.1	22.2	12.5	13.5	11.3	9.7	15.7	11.2	10.1	23.7	14.8	11.3	7.7	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0	56.6	43.9	35.8	19.9	7.4	27.8	34.3	28.1	53.5	48.9	26.2	51.1	10.2	6.6	13.9	65.8	11.3	19.0	23.3	11.5	10.2	12.0	21.1	17.4	26.0	12.8	20.6	8.7	16.5	16.7	13.3	17.0	11.5	3.3	13.6	22.8	15.1	11.3	17.6	21.5	6.4	32.6	12.9	11.2	12.1	13.1	9.8	15.1	13.1	16.7	16.1
NFXL1	HOZFP	ENSG00000170448	"Nuclear transcription factor, X-box binding like 1"	Q6ZNB6	4	47847233-47914667	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 100.7;Spermatocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059132	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059132: AB_2683917"	"unprognostic (5.37e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.26e-3)"	"unprognostic (8.48e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.72e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.01e-2)"	8.3	5.8	7.8	7.2	8.7	6.5	10.8	19.1	9.4	10.1	7.4	6.2	12.2	7.8	13.3	19.2	9.7	9.6	6.9	5.5	6.7	5.5	7.4	9.5	7.4	6.5	7.0	9.6	10.9	12.8	11.9	19.6	8.7	7.6	9.0	8.6	5.3	12.4	10.2	7.1	9.3	7.4	8.8	8.8	7.5	8.2	21.3	7.0	5.9	17.2	4.4	7.7	9.2	10.9	2.5	1.9	5.6	2.3	1.5	3.5	1.7	5.5	3.5	3.9	8.1	7.5	12.4	13.4	3.8	5.4	6.2	7.8	5.9	12.7	4.4	7.3	2.5	12.1	5.7	10.1	7.6	7.4	3.4	3.9	4.7	6.5	10.8	9.7	11.5	9.5	8.1	10.2	4.3	25.6	7.4	5.4	9.3	8.4	5.5	6.4	5.3	9.0	5.4	9.5	7.6	5.5	8.1	7.6	7.3	7.9	10.6	12.5	6.0	2.8	8.0	5.5	7.9	5.5	3.4	4.4	8.2	5.1	3.8	8.4	8.9	5.4	8.9	4.7	6.5	7.1	0.0	1.7	1.7	2.3	2.3	2.8	2.2	3.2	2.5	1.6	2.5	3.5	3.4	5.6	1.5	1.1	1.9	2.0	1.7	7.8	8.7	19.1	9.4	6.7	5.5	7.0	9.6	7.6	7.0	6.0	8.3	1.5	4.0	4.7	19.0	100.7	15.3	8.1	13.6	7.0	9.8	5.0	10.0	7.2	28.3	7.3	5.8	0.0	6.0	9.5	8.0	6.1	2.3	7.2	4.3	7.9	10.9	4.3	3.5	12.4	11.8	6.2	1.7	4.6	7.4	9.1	6.3	3.5	9.6	3.1	16.0	0.0	3.6	72.2	24.3	3.8	5.6	4.9	6.9	5.1
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	59.7	66.1	91.5	50.2	37.3	38.6	50.1	49.0	45.6	66.3	58.6	52.4	44.4	68.0	54.6	45.1	45.8	44.7	136.6	42.6	73.1	51.7	91.2	55.8	69.4	52.2	31.7	78.1	49.0	40.8	30.4	67.1	45.0	55.0	54.5	49.3	71.1	71.3	61.2	53.0	101.1	71.2	114.0	60.3	53.7	90.9	96.0	58.3	50.9	52.9	63.5	78.9	63.5	41.5	56.3	55.5	39.0	50.6	50.0	42.9	64.5	60.0	56.7	41.2	77.9	77.4	32.1	90.9	61.4	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0	71.5	74.4	79.8	78.6	112.2	63.2	53.3	94.3	53.5	84.2	41.8	39.3	104.8	48.0	113.5	9.9	89.5	55.4	70.0	96.7	148.6	89.4	78.5	84.5	108.5	99.0	50.9	134.1	70.0	136.1	12.1	98.7	83.7	54.0	104.6	95.9	77.6	111.2	84.2	120.2	93.8	45.1	64.7	107.2	22.8	62.3	107.0	108.8	84.7	122.4	84.4
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.8	9.7	14.1	12.4	8.5	6.8	11.2	8.3	8.6	12.7	9.9	11.7	7.9	13.6	6.1	9.3	8.0	9.1	15.1	8.4	13.0	13.0	10.8	11.3	8.2	7.9	6.2	13.8	11.3	5.8	7.9	12.5	12.1	7.3	9.3	13.3	13.6	10.5	7.7	10.8	27.0	13.0	13.1	10.9	8.7	17.2	11.4	12.1	7.2	8.7	12.2	13.3	12.5	13.0	8.4	12.0	8.1	13.2	7.2	7.2	10.0	8.4	15.2	11.5	11.4	24.2	7.6	12.8	13.9	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2	3.0	6.2	3.7	2.8	6.0	10.2	5.1	5.1	13.4	5.7	3.5	9.8	2.1	0.0	2.1	0.3	6.7	3.2	0.0	3.1	3.5	3.7	4.4	4.7	4.7	2.6	9.5	6.4	8.0	5.6	1.4	4.9	5.8	5.0	2.8	5.0	5.6	2.4	5.8	4.2	2.2	10.4	6.5	3.6	6.7	6.0	6.8	2.9	9.2	3.9	2.6
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468725	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	24.5	20.8	21.4	21.4	24.9	47.6	27.8	21.3	27.3	20.7	24.0	27.6	18.2	22.0	24.4	26.8	28.8	22.2	21.9	18.3	22.0	20.8	26.1	28.9	20.0	30.9	32.4	23.8	21.9	25.9	18.1	24.5	29.7	23.0	20.1	29.0	21.5	22.4	20.0	32.4	25.3	26.9	22.3	29.5	27.1	24.8	27.3	28.8	38.0	23.4	30.4	38.4	21.3	22.8	33.8	34.2	39.5	33.5	30.4	35.0	40.0	21.8	15.9	27.2	17.9	20.1	15.3	18.9	22.5	18.3	29.4	24.9	21.6	13.1	31.7	13.1	16.6	20.7	17.0	36.8	26.6	33.4	19.5	38.3	19.7	24.0	25.0	21.0	51.5	15.7	14.6	20.8	23.2	29.0	12.3	20.7	22.8	26.2	20.4	21.1	29.3	41.6	34.3	27.2	60.8	23.4	31.6	24.2	22.2	19.4	17.4	13.4	11.3	24.6	16.3	24.2	20.0	13.1	26.8	14.1	15.8	27.5	12.5	26.9	16.9	29.6	53.3	15.1	22.6	16.6	21.4	33.5	38.9	27.0	30.8	35.0	33.8	31.2	33.6	34.2	30.4	30.9	30.1	39.5	30.4	28.4	28.8	32.5	40.0	21.4	24.9	21.3	27.3	22.0	20.8	32.4	23.8	23.0	28.8	20.8	11.5	67.5	63.0	68.6	23.0	9.7	35.7	20.1	7.9	10.4	3.9	79.5	39.7	49.1	6.3	40.0	29.3	46.7	48.8	96.5	39.8	40.0	33.4	19.2	51.8	12.7	14.5	31.9	30.2	8.9	39.1	48.0	32.1	76.7	29.2	30.1	53.9	31.6	39.3	31.5	20.3	97.0	45.3	54.3	80.0	80.0	91.3	58.6	39.3	89.1
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.6	14.6	17.8	14.1	18.7	45.0	16.8	24.6	24.7	13.9	15.0	15.3	11.7	12.6	16.0	23.3	15.6	17.1	12.8	11.4	18.9	19.8	13.1	9.2	10.2	19.0	14.6	18.4	16.3	11.2	8.4	23.6	25.7	15.9	11.9	16.4	17.6	11.4	9.4	20.3	14.7	13.1	15.0	12.2	13.8	12.3	23.9	13.6	27.5	12.9	10.7	21.2	12.3	10.9	18.2	17.8	14.8	18.7	9.6	18.2	12.1	18.4	7.7	18.1	9.0	7.5	8.0	23.5	9.9	13.1	18.8	17.1	25.4	10.7	24.7	10.7	10.5	9.8	9.4	20.9	12.0	19.7	10.6	10.2	28.2	5.5	30.9	14.7	20.3	18.1	12.2	2.5	11.4	12.8	7.4	16.0	24.5	15.3	10.1	16.4	20.0	23.7	19.8	25.3	10.2	10.2	16.3	18.1	12.8	19.3	28.0	16.7	8.6	13.5	22.9	8.6	18.1	13.3	21.4	9.4	11.4	10.9	10.8	9.4	8.8	5.2	42.6	5.2	12.2	13.5	10.6	18.1	11.0	10.2	18.7	11.1	18.2	13.7	9.4	16.6	18.0	13.8	10.4	14.8	9.6	13.5	17.8	18.2	12.1	17.8	18.7	24.6	24.7	18.9	19.8	14.6	18.4	15.9	13.6	17.9	25.6	35.9	21.3	29.7	39.8	24.2	20.4	24.1	15.9	15.7	55.0	59.0	18.3	25.3	13.9	22.2	14.0	0.0	29.7	85.2	25.3	15.0	9.2	9.4	23.6	28.6	24.2	25.2	29.3	17.3	29.1	21.8	18.6	46.9	18.6	25.3	21.5	20.1	25.1	19.5	66.0	32.3	30.3	143.2	73.9	29.7	67.3	30.5	23.2	22.7
PURA	"PUR-ALPHA, PUR1, PURALPHA"	ENSG00000185129	"Purine rich element binding protein A"	Q00577	5	140107777-140125619	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA		150000				"unprognostic (2.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.77e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.09e-1)"	10.5	14.4	13.9	9.0	20.3	2.0	10.4	23.4	21.4	15.9	17.3	13.0	13.7	11.8	12.6	10.8	13.6	10.5	10.9	12.3	14.2	12.2	18.8	13.7	9.5	8.8	16.6	10.2	16.2	10.7	30.9	14.8	12.0	14.4	17.0	8.3	11.7	12.4	14.8	14.6	11.2	26.0	17.9	14.6	15.1	10.6	7.5	18.8	10.4	19.4	6.2	9.5	17.1	18.5	3.0	1.8	3.3	1.4	3.7	3.7	0.8	6.9	3.1	2.4	10.4	9.8	14.2	6.7	13.6	8.6	7.6	7.1	8.0	6.4	8.8	11.9	9.7	3.4	5.6	7.9	10.3	12.3	9.0	10.1	5.9	6.0	3.1	5.3	5.2	7.0	5.7	8.5	7.9	8.0	9.7	3.8	6.9	5.1	6.8	7.0	5.8	7.0	6.0	1.8	3.3	6.9	6.0	9.0	5.2	7.6	5.5	6.1	5.2	8.1	8.6	9.7	3.1	7.0	7.6	11.2	13.7	5.1	4.0	10.0	9.5	5.1	6.9	7.3	6.4	10.5	3.3	1.4	2.2	2.6	0.9	2.4	2.2	2.8	2.6	1.2	3.0	2.6	3.7	0.7	3.7	1.2	1.8	2.2	0.8	13.9	20.3	23.4	14.3	14.2	12.2	16.6	10.2	14.4	18.8	47.6	37.1	33.1	42.6	30.5	153.0	60.6	58.6	17.4	25.0	73.3	117.8	39.0	11.6	21.6	17.4	63.3	45.3	0.0	22.0	36.2	51.6	56.4	25.3	53.8	23.0	208.2	60.4	63.8	28.9	5.6	70.8	22.3	35.4	9.0	44.2	88.5	23.1	31.6	95.8	39.2	100.3	71.1	72.9	30.3	41.1	39.6	36.3	37.4	39.3	40.6
PURB	PURBETA	ENSG00000146676	"Purine rich element binding protein B"	Q96QR8	7	44876293-44885361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048766			Supported	Nucleoplasm		NA	NA		13000	Nucleoplasm		"HPA048766: "	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.22e-2)"	12.1	9.6	19.1	12.0	20.3	13.5	14.2	30.8	22.0	13.7	14.2	11.1	6.6	8.7	13.1	9.4	13.9	11.6	11.6	9.1	18.5	9.2	11.3	10.0	12.4	11.1	15.6	13.4	12.5	10.1	17.4	10.4	15.4	12.9	12.8	9.0	11.0	11.3	11.6	14.3	16.7	10.7	18.5	12.4	10.8	10.8	7.8	15.0	12.3	13.9	7.8	11.9	11.7	11.8	1.5	1.6	3.3	1.2	1.5	2.0	0.6	8.9	5.0	9.0	16.9	8.4	13.5	6.0	12.4	9.8	9.3	9.1	7.5	7.0	13.4	10.9	14.3	22.1	16.6	8.4	11.0	18.5	10.8	6.9	6.7	12.4	4.2	8.4	10.5	10.7	11.0	14.1	17.8	13.1	10.0	9.8	11.1	11.7	12.6	19.5	12.4	8.7	13.2	14.1	6.0	8.8	7.2	27.4	8.7	7.7	15.4	9.0	12.7	12.3	25.8	7.6	11.4	17.2	12.1	16.5	16.4	18.0	10.6	20.7	22.2	19.3	4.3	12.2	12.3	21.7	1.6	1.2	1.7	1.9	1.1	2.0	0.9	1.6	1.5	0.6	1.5	1.5	1.7	3.3	1.5	0.9	1.6	1.2	0.6	19.1	20.3	30.8	22.0	18.5	9.2	15.6	13.4	12.9	15.0	35.7	36.3	18.8	30.6	62.0	57.4	16.5	20.4	30.8	31.8	17.4	31.4	16.0	8.3	16.9	16.5	32.7	14.2	0.0	19.4	11.1	24.9	35.8	35.8	11.6	15.0	50.9	19.5	36.8	19.7	14.0	19.2	30.9	16.9	10.0	18.0	38.9	23.0	7.0	18.7	9.2	51.0	45.3	32.7	16.8	12.2	75.3	15.8	20.0	21.5	37.3
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	1.3	1.9	11.0	1.2	10.3	0.6	0.9	14.7	13.5	2.4	1.0	2.4	0.5	1.0	5.6	2.6	1.5	1.6	3.0	1.6	9.4	6.2	1.7	0.7	1.4	1.3	4.9	7.3	1.6	0.7	0.6	3.9	1.5	6.2	1.9	1.1	1.7	1.6	2.6	1.0	0.9	1.0	5.0	4.5	2.5	1.3	8.1	6.4	0.0	0.8	0.0	1.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.1	0.0	0.0	0.2	0.4	0.7	1.8	0.0	0.0	0.2	0.0	0.0	3.0	0.0	2.9	0.0	1.0	0.0	4.4	1.6	0.0	0.2	0.0	0.0	0.2	1.3	0.0	1.3	0.0	1.0	4.3	6.1	0.4	0.5	0.2	0.0	0.9	0.0	6.8	0.0	0.3	2.2	1.2	0.0	0.0	0.0	1.2	8.2	0.0	0.0	0.0	3.3	0.0	0.0	2.6	2.9	3.7	0.0	0.4	0.3	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.3	14.7	8.9	9.4	6.2	4.9	7.3	6.2	6.4	0.0	0.0	0.0	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	16.8	0.6	0.0	0.0	0.0	0.0	11.3	0.0	0.0	1.4	0.0	1.8	0.0	0.3	1.7	1.1	0.0	0.0	0.0	0.0	0.0
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049157: AB_2680658, HPA053330: AB_2682114"	"unprognostic (3.16e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.04e-3)"	16.2	11.0	15.8	19.5	17.8	28.4	15.6	7.6	15.3	19.5	20.1	14.9	17.4	16.9	16.6	20.3	21.8	25.3	12.8	17.7	14.3	12.7	19.0	11.3	14.3	22.5	16.0	10.1	18.8	17.9	12.2	14.0	21.9	13.6	17.7	9.0	16.1	27.0	22.4	32.0	18.7	15.3	11.9	13.0	26.5	16.7	8.5	9.3	49.6	36.6	21.8	23.4	15.1	13.8	25.1	31.7	28.4	18.2	18.3	23.3	15.7	18.6	11.7	8.3	16.6	2.9	8.2	20.9	9.3	9.8	16.0	15.9	9.7	39.1	18.4	23.9	9.6	6.8	13.9	7.1	18.4	7.1	12.6	11.1	14.6	11.9	14.1	30.5	20.8	31.1	15.6	10.9	14.0	10.3	9.8	15.9	18.3	29.1	21.0	8.7	37.4	27.1	27.7	10.0	19.7	26.6	23.0	8.5	32.0	13.2	13.1	6.9	14.4	9.7	12.4	22.8	5.8	17.9	42.6	15.5	8.8	9.3	20.7	14.9	24.3	26.3	27.3	12.7	26.0	16.7	20.5	17.7	28.4	15.1	18.2	12.6	23.6	16.9	16.3	20.0	25.1	17.1	16.5	7.6	18.3	13.3	31.7	23.3	15.7	15.8	17.8	7.6	15.3	14.3	12.7	16.0	10.1	13.6	9.3	29.8	34.6	34.2	28.5	19.6	7.8	3.3	25.5	41.5	14.8	29.6	2.0	50.0	64.6	40.6	4.0	26.3	43.3	23.3	49.9	50.7	21.3	23.9	32.2	13.6	54.2	14.3	35.7	31.3	48.3	7.6	28.1	33.6	20.3	68.5	37.0	24.1	47.4	36.8	18.0	53.8	10.1	38.8	25.9	5.2	17.2	21.5	38.1	28.0	39.4	21.3
RFXAP		ENSG00000133111	"Regulatory factor X associated protein"	O00287	13	36819224-36829104	"Disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	SCID	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032035			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA032035: AB_2674120"	"unprognostic (2.03e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.14e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.15e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.94e-1)"	"prognostic favorable (4.18e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.99e-3)"	8.5	6.7	15.0	8.8	14.4	9.2	9.0	31.8	15.6	12.7	9.5	12.3	8.4	5.7	13.1	10.2	5.8	10.9	7.7	6.4	13.0	9.1	6.2	5.0	8.1	11.5	13.3	10.8	13.9	9.3	11.9	14.2	7.0	11.3	10.3	8.1	9.8	8.8	11.3	8.1	6.5	8.7	11.1	10.5	9.1	7.9	11.7	14.5	19.7	11.2	4.6	9.8	8.0	8.1	1.4	1.9	2.4	0.6	0.7	1.3	0.0	4.5	1.1	6.6	9.3	2.5	3.4	4.3	3.7	3.9	7.0	4.3	3.2	3.7	19.9	3.1	3.3	6.2	4.2	6.8	2.2	7.9	14.8	11.3	9.5	5.0	6.2	4.5	17.4	7.0	3.1	4.1	3.4	2.6	2.0	5.2	15.3	5.4	4.0	2.1	2.2	17.3	12.5	7.1	3.9	2.0	15.2	12.3	6.0	3.0	2.8	5.4	6.8	3.6	2.4	2.8	4.2	2.4	10.4	4.0	1.8	3.9	6.3	3.3	3.8	3.1	15.0	5.1	12.1	2.8	0.0	0.1	2.4	1.0	0.0	0.8	1.4	0.6	1.1	0.1	0.5	0.7	1.3	0.0	0.7	0.6	1.9	1.1	0.0	15.0	14.4	31.8	15.6	13.0	9.1	13.3	10.8	11.3	14.5	3.0	3.8	3.9	2.8	3.2	14.7	2.4	2.5	1.4	2.3	3.5	2.0	5.2	13.3	2.8	3.1	4.5	2.0	0.0	4.7	2.8	9.3	1.5	10.3	2.4	2.7	22.3	6.9	8.6	1.6	2.9	10.3	5.0	6.8	2.8	2.4	21.6	2.7	2.9	10.3	1.2	16.3	6.5	6.4	14.6	23.3	1.8	1.0	12.8	4.0	0.7
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193148	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		280000	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	40.5	35.7	31.5	39.4	31.4	122.5	48.3	53.0	38.5	39.0	31.4	37.8	32.9	30.0	45.3	36.5	45.5	43.0	28.1	34.0	29.1	24.6	36.4	34.2	47.6	48.8	26.3	32.6	59.9	40.2	45.8	46.3	35.5	31.9	35.5	38.0	35.7	39.6	38.0	44.9	42.9	34.1	36.5	32.8	42.4	35.5	37.5	32.9	95.2	35.3	24.1	60.6	35.9	38.6	6.9	11.2	4.4	8.8	4.9	8.9	3.3	36.4	30.5	53.2	30.1	13.1	19.7	49.9	20.0	20.3	34.2	25.0	33.1	26.4	66.6	27.8	23.1	21.4	33.4	57.8	39.1	46.6	35.5	38.4	50.0	32.9	39.3	17.7	52.0	29.8	15.7	15.2	29.6	14.4	15.2	29.7	35.3	56.5	31.8	33.2	31.7	60.8	44.6	63.4	22.0	29.5	61.9	36.1	43.3	33.0	44.3	38.4	42.7	28.8	22.5	28.9	38.9	26.3	37.1	31.6	27.4	40.3	17.9	42.7	36.5	31.0	67.8	19.5	34.5	38.9	2.6	6.5	4.4	7.7	8.8	8.9	6.2	7.6	6.1	5.8	6.9	7.2	7.9	3.4	4.9	6.4	11.2	8.2	3.3	31.5	31.4	53.0	38.5	29.1	24.6	26.3	32.6	31.9	32.9	157.8	233.8	123.2	218.3	317.6	223.2	127.3	68.8	123.1	187.7	104.7	180.6	178.4	69.6	106.2	101.7	173.0	92.7	46.7	119.2	185.7	204.4	133.7	151.3	95.2	121.1	162.1	210.6	114.8	123.3	250.0	132.3	139.5	133.3	108.2	106.4	182.5	126.2	101.2	109.6	66.5	219.0	51.8	200.9	192.3	171.1	286.1	255.5	127.5	133.5	143.0
TCF25	"KIAA1049, Nulp1"	ENSG00000141002	"Transcription factor 25"	Q9BQ70	16	89873570-89913627	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041699, HPA041786"	Enhanced					NA	NA					"HPA041699: AB_10960254, HPA041786: AB_10960526"	"unprognostic (1.33e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (6.67e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.08e-1)"	42.4	52.8	46.6	45.6	60.3	69.6	40.6	53.9	77.3	41.1	43.4	41.9	48.3	50.3	47.7	41.4	45.6	48.4	49.2	47.2	41.2	48.0	39.4	49.3	38.6	45.7	42.6	58.1	58.1	57.1	55.5	52.3	66.2	54.7	40.5	31.3	41.5	50.3	49.6	50.8	48.6	44.9	45.2	38.3	46.2	47.1	62.5	40.8	30.9	58.9	29.8	42.8	45.1	37.5	29.0	41.9	66.4	38.9	22.2	30.0	20.4	15.2	22.7	25.3	33.6	20.8	22.6	28.3	37.7	28.4	28.7	13.4	14.6	23.5	36.3	30.2	26.9	9.7	15.7	14.1	16.4	11.6	15.1	30.1	18.4	21.8	28.2	35.0	21.4	25.4	27.2	17.0	17.7	19.4	28.5	25.4	14.6	33.4	22.4	29.4	50.3	23.3	41.3	16.3	23.4	12.6	37.1	24.2	20.5	24.3	21.4	22.7	14.0	57.2	21.6	20.5	11.1	21.1	22.4	39.0	24.2	25.9	13.6	15.8	28.7	9.8	20.5	23.6	25.3	30.5	26.9	38.9	29.6	30.0	30.9	22.4	21.1	22.2	23.3	26.5	29.0	19.2	19.9	66.4	22.2	27.8	41.9	18.8	20.4	46.6	60.3	53.9	77.3	41.2	48.0	42.6	58.1	54.7	40.8	148.9	149.4	162.0	135.2	90.9	329.9	75.8	109.5	179.3	127.4	157.1	261.1	183.9	126.0	98.3	219.0	125.4	175.9	0.0	131.9	260.8	154.9	152.2	166.5	127.3	138.5	438.6	142.2	113.5	136.8	247.7	160.5	149.3	177.2	162.3	142.1	162.2	106.1	150.8	173.2	108.3	256.8	155.2	135.8	170.6	63.7	90.8	450.6	173.0	133.9	143.1
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	27.2	14.9	13.2	21.5	15.1	32.8	19.3	14.4	19.7	16.6	16.0	20.1	12.1	14.5	21.3	17.4	13.1	17.2	19.2	16.5	12.3	12.0	16.5	13.4	28.2	20.5	13.4	13.8	18.3	12.2	23.8	14.6	17.4	17.1	15.5	14.4	21.1	14.4	13.7	23.0	17.6	20.6	18.3	14.4	25.9	16.2	23.9	14.6	18.6	21.4	14.4	22.7	16.8	15.0	5.7	5.1	30.0	14.0	5.6	8.3	5.4	5.8	9.1	2.2	3.1	12.1	9.5	3.7	8.0	18.9	50.3	21.0	10.4	4.9	4.9	10.3	15.9	14.3	11.4	4.1	10.8	17.5	4.6	1.3	5.8	6.6	4.5	10.5	4.6	7.1	10.0	10.2	11.2	8.4	9.2	7.6	2.9	4.4	6.1	12.5	2.4	5.0	3.1	2.1	5.1	7.7	3.2	7.5	1.3	8.3	8.1	2.2	1.6	11.8	23.0	8.2	2.8	5.9	3.9	18.8	24.7	7.0	8.9	7.7	4.0	1.4	2.7	9.9	3.2	5.4	8.8	6.7	10.8	8.3	8.8	7.3	5.7	8.3	7.8	5.1	4.6	8.0	6.1	30.0	5.6	14.0	3.0	6.0	5.4	13.2	15.1	14.4	19.7	12.3	12.0	13.4	13.8	17.1	14.6	38.7	29.3	17.4	18.7	24.6	14.7	11.4	12.7	29.4	22.7	19.2	9.8	5.5	0.0	20.8	27.6	39.1	15.6	0.0	19.7	6.0	27.4	21.6	26.5	11.5	14.0	11.1	12.6	26.4	25.9	16.0	21.0	25.7	18.6	27.9	11.0	37.0	25.1	17.5	25.5	6.3	12.7	0.0	28.4	41.6	5.7	19.1	9.5	15.2	9.7	31.2